study, 8 the possible difference between the arms was examined using mechanomyography but only until a train-of-four (TOF) of 0.70 was reached, and a possible difference between the dominant and non-dominant arms was not taken into account. Two methods will never agree well with one another if one of them has a poor repeatability (i.e. precision). To date, just two studies have examined the precision of mechanomyography and acceleromyography. 6 9 However, the first study included only six subjects. 9 We recently published another study 6 and showed a high precision of mechanomyography and of acceleromyography. Still, there was a significant bias between acceleromyography and mechanomyography which might be explained by the differences in baseline TOF values. We therefore suggested that all TOF values during recovery should be referred to the initial baseline TOF value (i.e. 'normalization'). 10 11 If, for instance, the mean TOF value before the neuromuscular block was 0.90, all TOF values during recovery referred to this value. Accordingly, a recorded TOF value of 0.45 was 'normalized' to 0.50 (0.45/0.90).
In accordance with the above, the first aim of our study was to evaluate the precision of acceleromyography and mechanomyography and its possible dependence on the arms (dominant and non-dominant). The second aim was to examine the possible differences (i.e. bias and limits of agreement) between the arms during recovery to at least TOF 0.90. The third aim was to evaluate whether normalization would change the bias between the arms.
Our primary hypothesis was that there would be neither any significant difference in precision between the dominant and non-dominant arms nor any significant bias between the arms.
Our secondary hypothesis was that if we-contrary to our primary hypothesis-found a significant difference between the arms, this could be explained by differences in baseline TOF values.
Methods

Patients
This trial is registered at ClinicalTrail.gov, NCT00472121. After approval by the local Ethics Committee of Copenhagen County, Denmark, and obtaining written informed consent, 40 female patients, ASA classes I-III and 18-65 yr of age, were enrolled. The anticipated duration of surgery should be more than 1 h and the patient placed in the supine position with both the arms available for neuromuscular monitoring. Patients with known illness/medications known to influence neuromuscular transmission, significant renal or hepatic dysfunction, allergy to medications used in the study, and pregnant or breast-feeding women were excluded. Only patients within 20% of the ideal body weight [ideal body weight (kg)¼height (cm)2106] were included.
Anaesthesia
The patients were monitored according to the department's routine (electrocardiography, non-invasive arterial pressure, pulse oximetry and capnography). Anaesthesia was induced and maintained with propofol and an opioid at the discretion of the anaesthetist. The trachea was intubated without the use of a neuromuscular blocking agent. Peripheral temperatures were measured bilaterally over the thenar eminence and kept above 328C. The central temperature was monitored in the oesophagus and kept above 358C. 3 All patients were placed under an upper body forced air warming blanket. Ventilation was adjusted to maintain normocapnia (end-tidal CO 2 4.5-5.6 kPa).
Neuromuscular monitoring
The recruitment of patients was divided into two parts: in the first part of the study (n¼20), mechanomyography was applied bilaterally, and in the second part (in another 20 patients), acceleromyography was applied at both the arms.
Part I
Two TOF-Watch w SX (Organon, Oss, The Netherlands) were modified to record the mechanomyographical response from a force transducer, TD 100 (Biometer International, Odense, Denmark). A triggering cable allowed the ulnar nerves to be stimulated simultaneously. Neuromuscular monitoring followed the Good clinical research practice guidelines in pharmacodynamic studies of neuromuscular blocking agents.
3 After careful cleaning of the skin, two paediatric surface electrodes (Neotrode w , ConMed Corporation, NY, USA) were placed over the ulnar nerves near the wrists with a distance of 3-6 cm. 6 To exclude any systematic measurement error of the force transducers and TOFWatch(es) (i.e. one of the monitors systematically measuring too high or too low values), the patients were randomized to have the triggering TOF-Watch w SX on the dominant or nondominant arm using a computer-generated number system and serially numbered, sealed, and opaque envelopes. Both the arms and fingers were tightly fixed to an armboard (Herlev armboard), 12 and the thumbs fixed to the force transducers with a preload of 200 -300 g. 6 After induction of anaesthesia, a 50 Hz tetanic stimulation was applied for 5 s and followed after 1 min by TOF stimulation every 15 s. When the response to TOF was stable, calibration and supramaximal stimulation was ensured by the built-in calibration function (CAL 2) of the TOF-Watch w SX. Stable baseline was documented in at least 2-5 min [,5% variation in the first twitch (T1) and TOF] before the neuromuscular blocking agent was administered. 3 The i.v. line was inserted in the forearm choosing the dominant or the non-dominant arm alternatively in a random matter. Rocuronium 0.6 mg kg 21 was administered in a fast-running saline infusion within 5 s. Data from the two TOF-Watch w SX were collected on a laptop using two modified TOF-Watch w SX monitor programs (version 2.4.MMG). The neuromuscular transmission was monitored to the end of surgery and at least to TOF ≥0.90 was achieved. When necessary, the neuromuscular block was antagonized with neostigmine and glycopyrrolate.
Arm-to-arm variation of MMG and AMG
Part II
This part was carried out as the first part, except that the response to nerve stimulation was measured using acceleromyography (TOF-Watch w SX, Organon). The piezo-electric acceleration transducer was placed at the volar side of the thumb in a small flexible preload device (Hand Adapter, Organon). 6 
Statistical analysis
The precision (or repeatability) was evaluated during recovery to at least TOF 0.90 and defined as the variance around a local linear regression line, involving nine consecutive TOF measurements over time, thus allowing for elimination of a possible trend. The variance was divided by the local squared average, yielding a squared coefficient of variation, which was then averaged over time to give a single coefficient of variation for each individual patient. These coefficients of variation were then compared using t-tests (on a logarithmic scale in order to achieve normal distributions). Accordingly, the precision is expressed as the geometric mean of the percentage coefficients of variation, meaning that the discrepancy between repeated observations of TOF is typically within +2 times this number. Hence, the lower the geometric mean, the higher the precision.
The following pharmacodynamic data obtained from the dominant and non-dominant arms were compared: onset time (time to ≥95% twitch depression of T1 in TOF), time to reappearance of the first, second, third, and fourth twitch in TOF (T1-T4), time to T1 25% (of the final T1), interval 25-75%, time to TOF 0.90 (with and without normalization), and the differences in the level of block during recovery at TOF 0.20-0.90 (with and without normalization). The time of a certain level of block was defined as the first occurrence of three consecutive values above the given block. If the TOF values in four consecutive measurements were 0.85, 0.91, 0.92, and 0.94, the time to TOF 0.90 corresponds to the time when TOF 0.91 was measured. In order to decrease the effect of random fluctuation (at first crossing, the value will typically be larger than expected), the level of block (TOF 0.20 -1.00) at this time was defined as the mean of the three values around the given block, using the above example the TOF value at 'level of block 0.90' was the mean of 0.85, 0.91, and 0.92, that is, 0.89. The TOF-Watch w SX does not calculate the TOF if T1 is below 20%. One of the three TOF values surrounding the 'level of block TOF 0.10' could therefore include zero, which made a significant bias and 'level of block TOF 0.10' is therefore not presented.
Graphical illustrations of the difference between the two methods against the average (Bland-Altman plots) proportional agreement) between the methods. A paired t-test was used when comparing responses obtained from the dominant and non-dominant arms.
The agreement between the dominant and non-dominant arms was assessed by the method described by Bland and Altman.
1 -3 The bias is defined as the mean difference of simultaneously obtained measurements at the two arms. The limits of agreement are defined as bias +2 SD, where SD denotes the standard deviations of the differences. Limits of agreement are interpreted as the reference range within which 95% of the differences will lie. The bias and the limits of agreement surrounding the bias (+2 SD) were calculated with 95% confidence intervals. When the TOF values were normalized, all TOF data were referred to the mean control TOF value during stable baseline (,5% variation in at least 2 min) just before the neuromuscular block was induced. If, for instance, the mean TOF value before the neuromuscular block was 0.90, all TOF values during recovery referred to this value. Accordingly, a recorded TOF value of 0.45 was 'normalized' to 0.50 (0.45/0.90).
The sample size was calculated using the following criteria (based on a paired t-test for comparing the arms): a power of 90% to detect a difference of at least 5% at TOF 0.90 (primary endpoint) with a significance level of 5%. We assumed the SD of the TOF values (the precision) to be 5% and the correlation between the arms to be 0.3. This demands a total of 16 patients in each part of the study. Because the correlation between the arms and SD were only estimates and to take possible dropouts into account, we included 2×20 patients.
Statistical analysis was performed using SAS 9.1 (SAS Institute Inc., Cary, NC, USA).
Results
All 40 patients (females; ASA I/II: 25/15; age: 26-65 yr; ideal weight: 217% to 18%) completed the study. There was no difference in supramaximal current between the arms (mean current 42.2 and 44.7 mA in part II; 37.6 and 38.3 mA in part I). Owing to the end of surgery, four patients were antagonized before TOF 0.90 was reached in part I (mean TOF 0.48, 0.59, 0.81, and 0.85) and one patient was antagonized in part II (mean TOF 0.62). In all five patients, data obtained after reversal were excluded because the pronounced shift in the rate of recovery made analysis of precision impossible.
The precision of both mechanomyography and acceleromyography was high, with no significant difference between the arms. For mechanomyography, the geometric mean was 2.12 (95% CI: 1.63-2.77) at the dominant arm and 2.38 (95% CI: 1.87 -3.03) at the non-dominant arm (P¼0.33). For acceleromyography, the geometric mean was 1.40 (95% CI: 1.23 -1.60) at the dominant arm and 1.55 (95% CI: 1.28-1.89) at the non-dominant arm (P¼0.10).
There was no significant difference in control TOF values between the arms during stable baseline before administration of rocuronium ( Table 1 ). The mechanomyographic mean control TOF was 0.97 (range 0.95 -1.00) on the dominant arm and 0.98 (range 0.95 -1.01) on the nondominant arm; the acceleromyographic mean control TOF was 1.10 (range 1.05 -1.21) on the dominant arm and 1.09 (range 1.05-1.16) on the non-dominant arm.
Also, there was no significant bias between the dominant and non-dominant arms for any of the pharmacodynamic parameters during recovery (Table 1) , but the onset time was statistically significantly longer on the dominant arm when measured with acceleromyography ( Table 1) .
The limits of agreement between the arms were wide for all pharmacodynamic parameters, for example, +20-30% difference in time to TOF 0.90. Figure 1 shows an example of a Bland-Altman scatter plot which was made for all endpoints.
There was no significant bias between the arms at any level of block during recovery, whether measured with mechanomyography (Table 2) or acceleromyography (Table 3 ) independent of whether the data were normalized (Tables 2 and 3 ). However, again the limits of agreement were very wide (+0.30 -0.40), although decreasing during late recovery (i.e. TOF .0.80) to +0.10-0.15.
Discussion
To our knowledge, this is the first prospective, randomized controlled study with the primary aims to evaluate both the precision and the arm-to-arm variation when monitoring neuromuscular function. The main findings of our study are: (i) the precision of both mechanomyography and acceleromyography was high, with no significant difference between the dominant and non-dominant arms. (ii) There was no significant bias between the arms at any level of block or in any pharmacodynamic parameters, whether recorded using mechanomyography or acceleromyography. The only exception was the onset time, which was significantly longer at the dominant arm, when measured using acceleromyography. (iii) The limits of agreement in TOF values and in different pharmacodynamic parameters used to characterize the course of the block varied widely at the two arms. During early recovery, the limits of agreement were very wide, but narrowed during progressive recovery.
Our findings of a high precision of both mechanomyography and acceleromyography confirm our previous findings 6 and indicate that the discrepancy between repeated Arm-to-arm variation of MMG and AMG Table 1 . Four patients were antagonized before TOF 0.90, and in one patient, the monitoring was stopped at TOF 0.88 and 0.90 at dominant and non-dominant, respectively. Therefore, only 15 data sets are presented. observations of TOF during recovery should be less than about 5% with both methods. We found no difference in precision and no bias during recovery between the dominant and non-dominant arms. When monitoring neuromuscular function, it is therefore not necessary to take dominance of the arms into account. The only significant bias we found between the dominant and non-dominant arms was in onset time when using acceleromyography. In eight of the 20 patients, the onset time was longest on the dominant arm (two patients with a difference of 30 s and six patients with a difference of 15 s). In the remaining 12 patients, there was no difference. We are not able to explain this bias, as we can exclude the site of injection of rocuronium, differences in peripheral temperatures, and the site of arterial pressure measurements as the course. Although in theory, it might be explained by differences in physiological characteristics of the arms, 13 our study offers no insight into this. examined the arm-to-arm variation using mechanomyography in 20 patients at different levels of block during recovery to TOF 0.70. In accordance with our findings, they found no significant bias between the arms.
Although we found no significant mean bias in any recovery parameter between the arms (Table 1) , the individual differences (limits of agreement) were wide: for example, the time to TOF 0.90 at one arm was often 15 -30% shorter or longer than at the other arm.
In contrast to the control baseline TOF values, where the variation was least with mechanomyography, there were wide limits of agreement between the arms at different levels of recovery with both mechanomyography and acceleromyography (Tables 2 and 3 ). The limits of agreement were particularly wide (+0.30-0.40) when the recovery slope was steep (i.e. TOF 0.30-0.70). At late recovery when a near plateau was reached (i.e. TOF .0.80), they were more narrow (+0. 10-0.15) . Surprisingly, the limits of agreement were comparable with those found earlier by us when the neuromuscular block was measured using acceleromyography and mechanomyography on the contralateral arms, 6 indicating that most of the individual differences found between the two methods could be explained by the arm-to-arm variation. This might also explain some of the variation in pharmacodynamic data found in studies of neuromuscular blocking agents, and in studies examining the relationship between the degree of neuromuscular block and signs, symptoms, and tests of residual paralysis. The difference between all patients were antagonized at T1 10%. This may very well have caused smaller individual differences due to a faster recovery. Furthermore, only two consecutive measurements at each arm were used to define the level of block, and if the two measurements differed more than 5%, the data were excluded. It is uncertain exactly how many data sets were excluded for this reason. Finally, the confidence intervals of the limits of agreement were not given. We expected that a possible bias could be explained by differences in control TOF values. However, there was no significant bias in control TOF values between the arms and the limits of agreement were relatively narrow. In accordance with this, normalization changed neither bias nor limits of agreement.
Data after reversal (n¼5) were excluded for two reasons. First, it makes no sense to evaluate the precision when a pronounced shift in the recovery curve is introduced at the time of reversal. Secondly, we believe that the differences in recovery and level of block between the arms would be falsely diminished. However, our power analysis was not compromised and an intention-to-treat analysis with all data included did not change our results significantly.
All patients were females undergoing gynaecological procedures. These procedures were chosen in order to diminish disturbances of the monitoring caused by the surgeon. Such disturbances would have decreased the precision and hence our ability to evaluate the agreement between the two arms. 2 3 We found both mechanomyography and acceleromyography to be very precise with no significant differences between the arms. However, in theory, we cannot exclude that males would react differently. In the mechanomyographic study (part I), we used two TOF-Watch w SX. The transducer (TD 100) is the same as used with the older 'Myograph 2000' (Biometer International), 12 but the TOF-Watch w is less sensitive to artifacts and the stimulation current circuitry is better, allowing constant current stimulation at a higher skin resistance (increased from 3.5 to 5 kV). 5 We believe that this increased the strength of the study. However, the modified TOF-Watch w SX is not commercially available.
In conclusion, both mechanomyography and acceleromyography are very precise methods with no significant difference between the arms. However, the individual arm-to-arm variation is often large, which might to a large extent explain the differences often found when two different methods for neuromuscular monitoring are compared on the contralateral arms.
